Vice President of Marketing

Cambridge, MA (On-site)

$250K/yr – $300K/yrSenior LevelFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and optimize global lead generation to fuel MQL/SAL growth with a senior B2B life sciences focus, collaborating closely with the CCO and GPLs on GTM strategy.

  • Must-have: 10+ years in marketing leadership with B2B life sciences or computational chemistry
  • Standout: Close, cross-functional GTM work with CCO and Global Portfolio Leaders

Job Description

Responsibilities

  • Own the global lead generation quota; develop and execute data-driven performance marketing strategies to aggressively grow Marketing Qualified Leads (MQLs) and Sales Accepted Leads (SALs)
  • Partner with the CCO and Global Portfolio Leaders (GPLs) to define go-to-market strategies for our Life Sciences and our Materials Science suites, ensuring product positioning translates directly into the commercial pipeline
  • Map and optimize the buyers’ journey from initial awareness through to advocacy, utilizing HubSpot, HighSpot, and Salesforce to track attribution and ROI
  • Direct the creation of high-impact technical content (white papers, case studies, webinars) designed to capture intent and move pharma/biotech decision-makers through the funnel
  • Identify emerging trends and competitive shifts in the market, ensuring Schrödinger’s value proposition remains the gold standard in computational chemistry

Requirements

  • At least ten years of marketing leadership experience (at least five years in B2B life sciences, biotech, or computational chemistry)
  • Extensive experience managing performance marketing budgets and hitting MQL/Pipeline targets
  • Bachelor’s degree or higher in a scientific discipline (Chemistry, Biology, or related field); an MBA is a plus
  • Expert-level proficiency with HubSpot, Salesforce, MS Office, and Google Suite
  • Robust experience in digital marketing via search and social media
  • Familiarity with the drug discovery life cycle and informatics platforms
  • Background in computational modeling or drug discovery informatics is a plus

Preferred

  • MBA is a plus
  • Experience with B2B SaaS or Life Science organizations (growth architect)

Benefits

  • healthcare (with dental and vision)
  • a 401k
  • pre-tax commuter benefits
  • a flexible work schedule
  • a parental leave program
  • regular catered meals in the office
  • a company culture that is relaxed but engaged
  • over a month of paid vacation time
Schrödinger logo

Schrödinger

4.3 Glassdoor

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Stay Alert: Avoid Recruitment ScamsAcross industries, cybercriminals are posing as company recruiters using fake job postings and employment offers.Please stay vigilant:- Never provide personal/financial information or payment to anyone claiming to offer a job opportunity- Always verify job postings through official company websites or direct contacts- Be cautious of unusual communication methods or overly quick offers

Founded in 1990
New York, New York, USA
997 employees
83% recommend to a friend
89% CEO approval

Traffic Signals

Monthly Visitors
146.3K
Monthly Google Ads Budget
$2.9K
Traffic Source Mix
Search
32.7%
Direct
23.4%
Referral
3.6%
Social
0.9%
Paid
0.3%

Headcount Trend

Current headcount: ~997

Funding

Total Funding
$577.2M
Last Raise
$10M
Grant, 2 years ago

Funding History

  • Jul 2024
    Grant • $10M
  • Nov 2021
    Grant • $4.9M
  • Aug 2020
    Post IPO Equity • $346.5M

Recent News